IL6 and hepatocellular carcinoma: The serum levels of interleukin (IL)‐6 and VEGF, which are inflammatory cytokines, are associated with an increased risk of HCC progression,39, 40, 41 suggesting that cytokine signaling pathways are correlated with hepatocellular carcinogenesis.